News Sentiment

BLRX sentiment intelligence

BioLineRx Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 15 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.01 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-6.7% over one week, -12.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to EBITDA forward of BioLineRX Ltd. – TASE:BLRX

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -6.7% Price reacting lower
Trend fit Trend inactive -12.5% over four weeks
Fair value -89.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 12
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 4
PR Newswire 4
dars.gov.et 3
TradingView 1
Market source 1
Zacks Investment Research 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 9
Earnings 4
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15